Viewpoints

Will Patient-Reported Outcomes Be Included in Oncology Product Labeling?

Will Patient-Reported Outcomes Be Included in Oncology Product Labeling?

FDA, industry, and patients are talking, but agreement on how to include patient experiences in oncology product prescribing information remains elusive.

Myth: Oncology Patients Demand Inappropriate Interventions

Myth: Oncology Patients Demand Inappropriate Interventions

According to a JAMA study, only 8.7% of patients with cancer requested medical interventions and only 11.4% of those were deemed inappropriate.

Feature Articles

Immunotherapies Shine at ASCO Annual Meeting

Immunotherapies Shine at ASCO Annual Meeting

FDA-approved immunotherapies are showing efficacy in different cancer types and combination therapies with new biologics are displaying increased efficacy.

Bone Cancer Resources

More Information

Bone Cancer Symptoms and Diagnosis

This fact sheet offers an overview of bone cancer as well as information on symptoms, diagnosis, and treatment.

Myelofibrosis Symptoms, Treatment, and Quality of Life

This fact sheet on myelofibrosis leukemia symptoms, treatment options and quality of life issues helps newly-diagnosed patients.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs